Scripps Research scientists engineered stable RSV and hMPV F proteins, overcoming instability challenges to design effective ...

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can ...

It is an illness that occurs primarily in children younger than 2 years old. It most commonly occurs in babies between 3 and 6 months old, with respiratory syncytial virus (RSV) being the primary ...

The prefusion conformation of the F protein is a significant target of potent neutralizing antibodies and is highly conserved across both RSV-A and RSV-B subtypes. The vaccine uses the same lipid ...

The Ontario government is expanding its vaccination program for infants and young children to protect against the respiratory syncytial virus (RSV). Starting Nov. 4, all babies born in 2024 will be ...

The just-opened immunization program is targeting respiratory syncytial virus (RSV), a seasonal disease that triggers mild symptoms in most but can be a particular threat to infants in their first ...

Seasonal viruses are beginning to make the rounds in the London region, an annual wave of illness that puts pressure on hospitals. In addition to flu and COVID-19 shots, respiratory syncytial virus ...